Timing of relapse in short-course chemotherapy trials for tuberculosis

International Journal of Tuberculosis and Lung Disease

Volumn 14, Issue 2, 2010, Pages 241-242

  Nunn, A J ^a   Phillips, Patrick P J ^a   Mitchison, D A ^b  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Clinical trials; Early relapse; Relapse; Timing; Tuberculosis

Indexed keywords

TUBERCULOSTATIC AGENT;

ARTICLE; CLINICAL TRIAL; FOLLOW UP; HUMAN; MEDICAL LITERATURE; MEDICAL RESEARCH; PRIORITY JOURNAL; RELAPSE; TREATMENT DURATION; TUBERCULOSIS;

AFRICA; ANTITUBERCULAR AGENTS; CLINICAL TRIALS AS TOPIC; FAR EAST; FOLLOW-UP STUDIES; HUMANS; RECURRENCE; TIME FACTORS; TUBERCULOSIS;

EID: 77049123034     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (1)

1. Fox W, Ellard G A, Mitchison D A. Studies on the treatment of tuberculosis undertaken by the British Medical Research Council Tuberculosis Units, 1946-1986, with relevant subsequent publications. Int J Tuberc Lung Dis 1999; 3 (Suppl 2): S231-S279.